产品中心Cell Resources
联系我们CONTACT US
400-999-210024小时服务热线
![HL-7702 [L-02; LO2] (人正常肝细胞) (Hela污染细胞系，暂不供应)](/Public/upfile/pic/xbx/CL-0111-1.jpg)
![HL-7702 [L-02; LO2] (人正常肝细胞) (Hela污染细胞系，暂不供应)](/Public/upfile/pic/xbx/CL-0111-2.jpg)
![HL-7702 [L-02; LO2] (人正常肝细胞) (Hela污染细胞系，暂不供应)](/Public/upfile/pic/xbx/CL-0111-3.jpg)
![HL-7702 [L-02; LO2] (人正常肝细胞) (Hela污染细胞系，暂不供应)](/Public/upfile/pic/xbx/CL-0111-4.jpg)
![HL-7702 [L-02; LO2] (人正常肝细胞) (Hela污染细胞系，暂不供应)](/Public/upfile/pic/xbx/CL-0111-5.jpg)
![HL-7702 [L-02; LO2] (人正常肝细胞) (Hela污染细胞系，暂不供应)](/Public/upfile/pic/xbx/CL-0111-6.jpg)
![HL-7702 [L-02; LO2] (人正常肝细胞) (Hela污染细胞系，暂不供应)](/Public/upfile/pic/product/cell-line-new.jpg)
![HL-7702 [L-02; LO2] (人正常肝细胞) (Hela污染细胞系，暂不供应)](http://www.procell.com.cn/Public/upfile/pic/xbx/CL-0111-1.jpg)
![HL-7702 [L-02; LO2] (人正常肝细胞) (Hela污染细胞系，暂不供应)](http://www.procell.com.cn/Public/upfile/pic/xbx/CL-0111-2.jpg)
![HL-7702 [L-02; LO2] (人正常肝细胞) (Hela污染细胞系，暂不供应)](http://www.procell.com.cn/Public/upfile/pic/xbx/CL-0111-3.jpg)
![HL-7702 [L-02; LO2] (人正常肝细胞) (Hela污染细胞系，暂不供应)](http://www.procell.com.cn/Public/upfile/pic/xbx/CL-0111-4.jpg)
![HL-7702 [L-02; LO2] (人正常肝细胞) (Hela污染细胞系，暂不供应)](http://www.procell.com.cn/Public/upfile/pic/xbx/CL-0111-5.jpg)
![HL-7702 [L-02; LO2] (人正常肝细胞) (Hela污染细胞系，暂不供应)](http://www.procell.com.cn/Public/upfile/pic/xbx/CL-0111-6.jpg)
![HL-7702 [L-02; LO2] (人正常肝细胞) (Hela污染细胞系，暂不供应)](http://www.procell.com.cn/Public/upfile/pic/product/cell-line-new.jpg)
产品概述
| 名称 | HL-7702 [L-02; LO2] (人正常肝细胞) (Hela污染细胞系，暂不供应) |
| 别称 | L02; LO2; HL-7702; HL7702 |
| 背景描述 | HL-7702 [L-02]细胞是人正常肝细胞；HL-7702 [L-02]细胞群体倍增时间约为20小时，细胞形态呈上皮样细胞。在电子显微镜下，亦显示上皮细胞所具有的桥粒和张力原纤维，HL-7702 [L-02]细胞增殖迅速，AFP与CK-19表达阴性，ALB表达在10μg/ml水平，部分细胞多次传代后发生形态变异，ALB表达缺失。(STR检测位点同HELA) |
| 种属 | 人 |
| 生长特性 | 贴壁细胞 |
| 细胞形态 | 上皮细胞样 |
| 细胞类型 | 肿瘤细胞 |
| 肿瘤类型 | 宫颈癌细胞 |
| 生长培养基 | RPMI-1640＋10% FBS＋1% P/S |
| 推荐传代比例 | 1:3-1:4 |
| 推荐换液频率 | 2~3次/周 |
| 冻存条件 | 冻存液：55% 基础培养基+40%FBS+5%DMSO 温度：液氮 |
| 培养条件 | 气相：空气，95%；CO2，5% 温度：37℃ |
参考文献
-
A new cell-free therapeutic strategy for liver regeneration: Human placental mesenchymal stem cell-derived extracellular vesicles(2022/10/20)
作者：Ting Li, Yu Fu, Zeyi Guo
期刊：Journal of Tissue Engineering
影响因子 ：7.9400
-
Preparation of Betulinic Acid Galactosylated Chitosan Nanoparticles and Their Effect on Liver Fibrosis(2022/09/14)
作者：Zichao Wu, Xinyu Liu, Jiayan Liu
期刊：International Journal of Nanomedicine
影响因子 ：7.0330
-
Metabolic Syndrome Ameliorated by 4-Methylesculetin by Reducing Hepatic Lipid Accumulation(2022/09/09)
作者：Linghuan Li, Guangyao Zhu, Gaohang Fu
期刊：INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
影响因子 ：6.2080
引用产品：CL-0111
-
A Dioscorea opposita Thunb Polysaccharide-Based Dual-Responsive Hydrogel for Insulin Controlled Release(2022/08/13)
作者：Wei Liu, Xiaoge Wang, Danyang Zhou
期刊：INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
影响因子 ：6.2080
引用产品：CL-0111
-
Carbon Dots Embedded Hybrid Microgel with Phenylboronic Acid as Monomer for Fluorescent Glucose Sensing and Glucose-Triggered Insulin Release at Physiological pH(2022/09/03)
作者：Jinhua Zhu, Wei Liu, Bowen Zhang
期刊：Nanomaterials
影响因子 ：5.7190
引用产品：CL-0111
-
Development of Glycyrrhetinic Acid and Folate Modified Cantharidin Loaded Solid Lipid Nanoparticles for Targeting Hepatocellular Carcinoma(2022/10/11)
作者：Yilin Xu, Min Wang, Shuangcheng Ning
期刊：MOLECULES
影响因子 ：4.9270
引用产品：CL-0111
-
Peroxiredoxin 5 protects HepG2 cells from ethyl β-carboline-3-carboxylate-induced cell death via ROS-dependent MAPK signalling pathways(2022/09/06)
作者：Danping Xie, Yixi Gong, Jaihyung Lee
期刊：Journal of Cancer
影响因子 ：4.4780
-
CSTF2 Acts as a Prognostic Marker Correlated with Immune Infiltration in Hepatocellular Carcinoma(2022/09/12)
作者：Wang Zhang, Yipeng Wan, Yue Zhang
期刊：Cancer Management and Research
影响因子 ：3.6020
-
Fuzi-Lizhong Decoction Alleviates Nonalcoholic Fatty Liver Disease by Blocking TLR4/MyD88/TRAF6 Signaling(2022/08/26)
作者：Jiayao Yang, Ying Zhang, Hongfeng Yi
期刊：Evidence-based Complementary and Alternative Medicine
影响因子 ：2.6500
引用产品：CL-0111
